Skip to main content

Table 1 Immunohistochemical analysis of tumor specimens

From: A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report

 

PD-L1

CD4/HPF

CD8/HPF

FOXP3/HPF

CD8/FOXP3

CD8/CD4

Neck primary (pre-treatment)

20%

75

111

31

3.58

1.48

Metastatic brain (post-treatment)

10%

53

69

9

7.67

1.3

  1. HPF high-power field; immunohistochemistry methods described in Additional file 1